Oculus Innovative Sciences Inc (NASDAQ:OCLS)

CAPS Rating: 1 out of 5

The Company has developed and it manufactures and markets, a family of products intended to prevent and treat infections in chronic and acute wounds.

Results 1 - 12 of 12

Recs

0
Member Avatar chrispycrunch (53.91) Submitted: 3/27/2014 9:36:28 AM : Underperform Start Price: $4.51 OCLS Score: +27.50

Speculators confused Oculus with Oculus VR, the company Facebook is buying. Short on this error.

Recs

0
Member Avatar chris293 (87.15) Submitted: 11/10/2013 8:06:57 PM : Underperform Start Price: $2.72 OCLS Score: -17.66

OCLS seems to have a funny problem, when they have increases in revenue, they company seems to have bigger losses in earning per share. Can anyone explain this?

Recs

0
Member Avatar kirpi4 (< 20) Submitted: 7/12/2013 12:56:03 PM : Outperform Start Price: $3.04 OCLS Score: -2.21

will grow up

Recs

0
Member Avatar zjmoser (< 20) Submitted: 4/2/2013 3:39:56 AM : Outperform Start Price: $3.46 OCLS Score: -23.06

Growth prospects

Recs

0
Member Avatar import2udirect (90.44) Submitted: 4/24/2012 11:47:27 AM : Outperform Start Price: $6.97 OCLS Score: -87.97

down because the market is down long term could be a winner

Recs

1
Member Avatar Casew (< 20) Submitted: 2/25/2012 10:53:31 AM : Outperform Start Price: $9.17 OCLS Score: -100.83

When this company went public back in 2007, it's share price peaked at around $11. It has steadily gone down since then and now typically trades at a little over $1.

What's interesting about this is that it's revenue has actually grown from $94,000 in 2004 to $9,754,000 in 2011. Expenses have not grown with the revenue, it has high profit margins, and excellent management.

This stock is dramatically undervalued, currently selling at the bargain price of $1.26. One day this company is going to catch Wall Street's eye, and when that happens we'll see the share price go through the roof.

Recs

0
Member Avatar ctsolomonmd (< 20) Submitted: 2/13/2012 1:20:58 PM : Outperform Start Price: $9.17 OCLS Score: -101.58

totally under the radar. positive free cash flow per share. Huge market with disruptive technology. Medicare won't pay for wound infections and this company has a reasonable remedy. I own this stock.

Recs

0
Member Avatar HollowMountain (< 20) Submitted: 2/6/2011 2:12:45 PM : Outperform Start Price: $13.51 OCLS Score: -117.23

This company has had some problems in the past, but it sells a brand that is important in the healthcare field and is only going to expand in business as people look for cheaper alternatives to expensive prescription medications.

Recs

0
Member Avatar targetphil3 (< 20) Submitted: 10/14/2010 10:38:17 PM : Outperform Start Price: $12.25 OCLS Score: -130.48

wonder if new acne meds do good in mexico? I actually hope they market to military for wound treatments.

Recs

1
Member Avatar HGPD99 (< 20) Submitted: 9/20/2010 11:43:45 AM : Outperform Start Price: $10.64 OCLS Score: -131.67

Amazing new products in the medical field.

Recs

1
Member Avatar Hanks98 (< 20) Submitted: 8/6/2007 5:47:18 PM : Outperform Start Price: $67.41 OCLS Score: -129.52

Announcing their final FDA approval in September and the distribution deals will follow. This stock is a 10 bagger over the next year.

Recs

0
Member Avatar IndexTrojan (55.21) Submitted: 1/26/2007 1:03:55 PM : Underperform Start Price: $55.44 OCLS Score: +133.41

Oculus Innovative Sciences, Inc. is a medical technology company focused on the development, manufacture and marketing of a family of products intended to help prevent and treat infection in acute and chronic wounds. Oculus’ platform technology, called Microcyn

Results 1 - 12 of 12

Featured Broker Partners


Advertisement